First Time Loading...

Centro de Imagem Diagnosticos SA
BOVESPA:AALR3

Watchlist Manager
Centro de Imagem Diagnosticos SA Logo
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Watchlist
Price: 11.03 BRL 3.67% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

AALR3 Price Targets Summary
Centro de Imagem Diagnosticos SA

Wall Street analysts forecast AALR3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AALR3 is 20.91 BRL with a low forecast of 20.71 BRL and a high forecast of 21.53 BRL.

AALR3 Lowest Forecast
Wall Street Target
20.71 BRL
88% Upside
AALR3 Average Forecast
Wall Street Target
20.91 BRL
90% Upside
AALR3 Highest Forecast
Wall Street Target
21.53 BRL
95% Upside
Lowest
Price Target
20.71 BRL
88% Upside
Average
Price Target
20.91 BRL
90% Upside
Highest
Price Target
21.53 BRL
95% Upside
Centro de Imagem Diagnosticos SA Competitors:
Price Targets
4694
BML Inc
9% Upside
H
AIDX
Healwell Al Inc
7% Downside
PRVA
Privia Health Group Inc
47% Upside
D
D
Dental Corporation PCL
12% Upside
4694
BML Inc
9% Upside
H
AIDX
Healwell Al Inc
7% Downside
PRVA
Privia Health Group Inc
47% Upside
D
D
Dental Corporation PCL
12% Upside
PIII
P3 Health Partners Inc
300% Upside
AMED
Amedisys Inc
8% Upside
PINC
Premier Inc
28% Upside
ADUS
Addus Homecare Corp
6% Upside

Revenue
Forecast

Revenue Estimate
Centro de Imagem Diagnosticos SA

For the last 8 years the compound annual growth rate for Centro de Imagem Diagnosticos SA's revenue is 7%.

7%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Centro de Imagem Diagnosticos SA

For the last 8 years the compound annual growth rate for Centro de Imagem Diagnosticos SA's operating income is -14%. The projected CAGR for the next 2 years is 101%.

-14%
Past Growth
101%
Estimated Growth
Estimates Accuracy
-23%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Centro de Imagem Diagnosticos SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

See Also

Summary
AALR3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AALR3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AALR3 stock valuation using valuation multiples.
Wall Street Estimates
AALR3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AALR3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AALR3's stock price target?
Price Target
20.91 BRL

According to Wall Street analysts, the average 1-year price target for AALR3 is 20.91 BRL with a low forecast of 20.71 BRL and a high forecast of 21.53 BRL.

What is Centro de Imagem Diagnosticos SA's Operating Income forecast?
Projected CAGR
101%

For the last 8 years the compound annual growth rate for Centro de Imagem Diagnosticos SA's operating income is -14%. The projected CAGR for the next 2 years is 101%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.